Regardless of whether apoptosis or necrosis are elicited by toxicants or by pathophysiological conditions, they are considered conceptually distinct forms of cell death. Nevertheless, there is increasing evidence that classical apoptosis and necrosis represent only the extreme ends of a wide range of possible morphological and biochemical deaths. The two classical types of demise can occur simultaneously in tissues or cell cultures exposed to the same stimulus and, often, the intensity of the same initial insult decides the prevalence of either apoptosis or necrosis. The execution of the death programme seems to involve a relatively limited number of pathways. In many instances, their ordered execution results in characteristic morphological and biochemical changes termed apoptosis. However, some subroutines of the degradation programme may not be active in all cases of cell death. Then, the morphological appearance of dying cells and some of their biochemical alterations differ from those of classical apoptosis. We have recently shown that intracellular energy levels and mitochondrial function are rapidly compromised in necrosis, but not in apoptosis, of neuronal cells. Then we went on to show that pre-emptying human T-cells of ATP switches the type of demise caused by two classic apoptotic triggers (staurosporine and CD95 stimulation) from apoptosis to necrosis. Conditions of controlled intracellular ATP depletion, obtained by blocking mitochondrial and/or glycolytic ATP generation, were used in combination with repletion of the cytosolic ATP pool with glucose to redirect the death programme towards apoptosis or necrosis.
two entirely distinct forms of cell death?
The term programmed cell death has been used mainly to describe the coordinated series of events leading to genetically controlled cell demise in developing organisms [1] . Various genetically encoded programmes involved in signalling or in the initiation of cell death may in fact decide the fate of individual cells or organs during development. Nevertheless, one class of death-related genes, those expressing caspases (cysteine aspartases), can execute death signals in virtually every cell [2] , and caspases seem to be constitutively expressed [3] . The type of cell death is frequently defined by morphological criteria [4] . Indeed, the term apoptosis [4] was initially introduced to define cells that shrink and undergo a series of typical nuclear changes, including chromatin margination and condensation, while in the cytoplasm, organelles appear to be intact. The concept of a death programme is, however, not necessarily linked to a morphological appearance. For example, in non-vertebrate systems, programmed cell death does not always display an apoptosis-like morphology [5] . This suggests that the shape of cell death is controlled by multiple factors. Several forms and subroutines of the death programme might have evolved because of their significance for tissues and organs and may not be common to all apoptosis models. This may be particularly relevant when considering that inhibiting one subroutine of the cell death programme may not result in cell survival, but rather in a different type of cell death [6] [7] [8] . Evidence that cells triggered to undergo apoptosis are instead forced to die by necrosis when energy levels are rapidly compromised has been provided recently [6] . Thus, the initial death signal is propagated without leading to apoptosis. This suggests the possible existence of different execution subroutines that become active depending, at least in part, on the intensity of the death signal, and may involve several proteolytic systems.
Different subroutines of cell death: the mitochondrial and non-mitochondrial pathways
It is not surprising that initially simple death programmes, developed early during phylogeny, undergo complex modifications in mammalian cells. Large gene families have evolved to provide a more intricate control of cell death in higher organisms, in part perhaps to accommodate the need for individual organ differentiation. Some characteristics of the original cell-death machinery that would affect predominantly the shape of death may have become more significant or predominant in some subsets of mammalian cells. A further consequence of the increased complexity may be that an increasing number of feedback loops gives rise to multiple possibilities of initiation, control and execution. Assuming that the whole core of the death programme is highly conserved, as shown by the pioneering studies in Caenorhabditis elegans [9] , it seems unlikely that a single linear pathway is solely responsible for the execution. Should this be the case, viruses and transformed cells capable of completely evading or shutting down a single programme would have evolved.
Also, it is difficult to conceive a single linear pathway, which the plethora of signals causing mammalian cell death would converge on. In higher organisms, additional interrelated or independent pathways may have therefore developed to regulate death.
Caspases are constitutively expressed in mammals, similar to ced-3 in C. elegans [3, 10] . However, in mammalian cells, different sets of caspases may be recruited in different paradigms of cell death. Deletion of single caspases has only localized and partial effects on cell death [11, 12] , and several forms of demise seem to be caspase-independent [8, 13, 14] or even inhibited by caspases [15] . Indeed, other protease families have also been implicated in apoptotic cell death [16, 17] . Furthermore, in some cases, caspase inhibition does not alter the extent of cell death, but rather the shape of demise [6, 8, 13, 14] .
The existence of alternative and perhaps reverberating pathways may also warrant a more effective elimination of injured, unwanted cells. Recently it has become clear that self-amplification of death signals requires the co-operation of mitochondrial and cytoplasmic factors. Under stressful conditions, the mitochondrial inner membrane can lose its impermeability to ions and other small molecules up to a molecular mass of approximately 2 kDa [18] . This event is defined as permeability transition (PT). Accumulating evidence supports the idea that PT is a controlled process, involving the formation of pores at contact sites between the inner and outer mitochondrial membranes. Pore opening can also occur following a selective proteolytic step (activation of calpain or caspase-1) [19, 20] . PT may be closely related to cell death (apoptotic and necrotic) induced by a wide variety of different stimuli. Extensive work performed in Dr. G. Kroemer's laboratory has shown that PT can lead to typically apoptotic nuclear alterations [21] , possibly caused by the release of a 50 kDa protein, apoptosis-inducing factor (AIF). PT and the release of AIF seem to be inhibited by Bcl-2, a ubiquitous negative controller of apoptosis [21] . Alternatively, it has been proposed that mitochondria can release holocytochrome c (cyt c) in cells undergoing apoptosis [22] [23] [24] . Cyt c is a small protein that is, at least in part, loosely attached to the outer surface of the inner mitochondrial membrane. In contrast to the mechanisms operating after PT, cyt c can also be released from energized mitochondria, i.e. when the integrity of the inner membrane is maintained. Notably, cyt c release from energized mitochondria can also be prevented by Bcl-2 [22, 23] . Neither the mechanism of cyt c release, nor the mechanism whereby PT and/or AIF/cyt c release are negatively regulated, have yet been elucidated. It is instead apparent that cyt c in conjunction with a cytosolic protein named APAF-1 and either ATP or dATP can activate caspases [22] .
ATP and the shape of cell death
Under pathological conditions in vivo, apoptosis and necrosis may often co-exist [25] and previous work in our laboratory has shown that intracellular energy levels are rapidly dissipated in necrosis, but not in apoptosis, of cultured neurons [26] .
To examine the events that determine the mode of execution of cell death (apoptosis or necrosis) following exposure to a single insult, individual parts of the death programme can be blocked by manipulating the intracellular ATP level. With this approach it has been possible to determine that when ATP levels were reduced, typical apoptotic stimuli instead caused necrosis [6] . ATP could be either depleted or repleted to defined levels and for defined periods of time. Therefore, it has been possible to identify a defined period of time after the exposure of lymphoid cells to apoptogenic stimuli, such as staurosporine or an agonistic anti-CD95 monoclonal antibody, during which energy-dependent steps are required to complete the apoptotic programme. If ATP concentrations are markedly reduced during this period, activation of downstream caspases and all typical apoptotic changes are blocked. Stimulated cells die nonetheless. However, death has necrotic features. These findings provide direct evidence that the complete apoptotic programme involves energyrequiring steps. More recent work suggests that one ATP-requiring step may be at the level of the formation of the protein complex between APAF-1, cyt c and procaspases [27] . Lack of ATP at this step would prevent the resulting downstream degradative processes, including caspase-3 activation, poly(ADPribose) polymerase cleavage and lamin cleavage, and exposure of phosphatidylserine on the outer membrane.
Intracellular protein localization or transport may also be relevant in determining the shape of cell death. Some death signals (e.g. those activated after irradiation or treatment with topoisomerase inhibitors) are predominantly generated within the nucleus. Since controllers and execution systems are believed to be located in the cytoplasm/mitochondria, as-yet-unknown death signals have to be transmitted from the nucleus to these compartments. Also, some caspases seem to be transported from the cytoplasm into mitochondria or the nucleus [28] . Thus, the permeability of the nuclear pore and/or the accessibility of mitochondrial sites may be relevant factors in deciding execution of individual subroutines in apoptosis [29] .
